View Article

  • Research Paper on Formulation and Evaluation of Herbal Blood Thining Tablet

  • Gajanan Maharaj College of Pharmacy ,Chh.Sambhajinagar.

Abstract

In this project we making a natural tablet that helps thin the blood using three main ingredients: curcumin (from turmeric), garlic extract, and vitamin E. Each of these has health benefits, especially for the heart. Curcumin can help reduce inflammation and prevent blood clots. Garlic is known to improve blood flow and reduce how sticky platelets are, which helps prevent clots. Vitamin E is an antioxidant that may also stop clots from forming too easily. By combining these ingredients, the goal is to create a safer, more natural alternative to chemical blood thinners, with fewer side effects. The tablet was made using standard methods and tested for things like strength, how fast it breaks down, and how evenly the ingredients are mixed. Early lab tests show it may help stop platelets from clumping together, which is a key part of blood clotting. More research is needed, but the results so far are promising for people looking for natural support for heart health.

Keywords

support healthy blood flow, Promotes Cardiovascular Health, Reduce Blood Pressure, Supports Anti-inflammatory Action, Reduces the risk of clot formation

Introduction

Natural blood thinning tablet also known as anticoagulant tablet that helps to reduce clot that from in blood. heart and blood vessels work hard every day to keep you going. But sometimes, poor circulation or thick blood can increase the risk of clots, which can lead to serious health issues. Our Natural Blood Thinning Tablet is a gentle, plant-based supplement made to support healthy blood flow and keep your circulation running smoothly. Packed with powerful herbs like garlic, ginger, turmeric, and ginkgo biloba, this tablet helps naturally thin the blood and reduce clot formation without the side effects of strong chemical medications. These ingredients have been used for centuries in traditional medicine to support heart health, reduce inflammation, and improve circulation. It’s perfect for anyone looking to support their cardiovascular system, especially if you're sitting for long periods, traveling often, or just want to take proactive care of your heart and blood vessels. Taken daily, it can be a simple and natural part of your wellness routine.

Drugs And Excipients profile:

1. TURMARIC (CURCUMIN ) :

Curcumin possesses notable anticoagulant (blood-thinning) properties, which contribute to its ability to support cardiovascular health. This effect is primarily due to curcumin’s ability to inhibit various factors involved in the coagulation cascade and reduce platelet aggregation

  • Scientific name: Curcuma longa
  • Common name: Turmeric
  • Part used: Rhizome (underground stem)
  • Family: Zingiberaceae
  • API: CURCUMIN

Major Chemical Constituents:

1.Curcuminoids (2–6%) — These are the principal bioactive compounds:

-Curcumin (77% of total curcuminoids) — bright yellow pigment, the main active compound with antioxidant and anti-inflammatory properties.

-Demethoxycurcumin

-Bisdemethoxycurcumin

2. Volatile oils (3–7%) — Responsible for aroma and some therapeutic effects:

Turmerone (α-turmerone and β-turmerone)

-Zingiberene

-Atlantone

-Sabinene

 3. Other constituents:

-Resins and polysaccharides (e.g., ukonan – has immunomodulatory activity)

-Proteins, sugars, and minerals

-Starch (major carbohydrate component)

Uses:

  1. Wound healing – Speeds up tissue repair.
  2. Anti-inflammatory – Reduces inflammation (e.g., arthritis).
  3. Antioxidant – Fights oxidative stress, slows aging.

2. VITAMIN E:

Vitamin E is a fat-soluble vitamin known primarily for its antioxidant properties, but it also plays a role in blood thinning. It acts as a natural anticoagulant by interfering with processes that lead to blood clot formation. One of its key actions is inhibiting platelet aggregation, which means it helps prevent blood cells (platelets) from clumping together to form clots.

 Major Chemical Constituents:

  1. Tocopherols: α, β, γ, δ (saturated side chain)
  2. Tocotrienols: α, β, γ, δ (unsaturated side chain)

Mechanism of Action:

1. Inhibition of Platelet Aggregation

How it works: Vitamin E reduces the activation and aggregation of platelets by:

Inhibiting protein kinase C (PKC), an enzyme involved in platelet activation.

Reducing the production of thromboxane A2, a compound that promotes platelet clumping and vasoconstriction.

2. Antagonism of Vitamin K Activity (at high doses)

How it works: High doses of Vitamin E can antagonize Vitamin K-dependent carboxylation of clotting factors II, VII, IX, and X.

3. Antioxidant Protection of Blood Vessels

How it works: Vitamin E neutralizes free radicals, protecting endothelial cells (lining of blood vessels) from oxidative stress and inflammation.

Benefits of a Vitamin E :

  1. Supports heart health by improving blood circulation and reducing clot risk.
  2. Combines antioxidant (vitamin E) and natural blood-thinning herbs for synergistic effect.
  3. May reduce inflammation and improve vascular function.

Garlic (Allicin)

Allicin, the active compound derived from freshly crushed garlic (Allium sativum), acts as a natural anticoagulant with multiple beneficial effects on the blood and cardiovascular system. Its primary mechanism is the inhibition of platelet aggregation, which helps prevent blood cells from clumping together to form clots

Mechanism Of Action:

1. Inhibition of Platelet Aggregation

Allicin suppresses platelet activation and prevents platelets from clumping together.

This is primarily achieved by inhibiting thromboxane A2 synthesis, a molecule that promotes platelet aggregation and vasoconstriction.

By reducing thromboxane levels, allicin helps maintain smoother blood flow and reduces clot formation.

2. Modulation of Arachidonic Acid Pathway

Allicin influences enzymes in the arachidonic acid cascade, which are involved in producing prostaglandins and thromboxanes.

This action contributes to its anti-inflammatory and antithrombotic (anti-clotting) effects.

3. Antioxidant Activity

Allicin’s antioxidant properties protect endothelial cells (lining of blood vessels) from oxidative stress.

Healthy endothelium is crucial in preventing abnormal clot formation.

4. Mild Fibrinolytic Support

Allicin may enhance fibrinolysis—the body’s process of breaking down existing clots—by promoting natural clot-dissolving enzymes.

Benefits of garlic :

1) Cardiovascular Health:

- Blood pressure management: Garlic may help lower blood pressure.

- Cholesterol reduction: Garlic may help reduce cholesterol levels.

2) Immune System:

- Infection prevention: Garlic's antimicrobial properties may help prevent infections.

- Immune system support: Garlic may help support immune function.

3) Antimicrobial Properties:

-Antibacterial effects: Garlic may help combat bacterial infections.

- Antiviral effects: Garlic may help combat viral infections.

4) Other Potential Benefits:

- Antioxidant effects: Garlic may help protect against oxidative stress.

EXCIPIENT:

ACACIA:

Acacia, commonly known as Gum Arabic, is widely used as a natural binder in herbal tablet formulations.  Primarily, it acts as a binder, helping to hold the powdered herbal ingredients together into a cohesive and stable tablet form. It also contributes to the mechanical strength of the tablet, improving hardness.

STARCH POWDER:

Starch is a widely used natural excipient in herbal tablet formulations, valued for its binding, disintegrating, and filler properties. It is typically derived from sources like corn, potato, rice, or tapioca, and is composed mainly of amylose and amylopectin, two polysaccharides that contribute to its functional versatility. In herbal tablets, starch is often used as a binder.

AGAR-AGAR POWDER:

 Agar-agar powder, a natural poly saccharide derived from red algae is occasionally used as a disintegrant in herbal tablet formulations. Known for its gel-forming ability in aqueous environments, agar-agar facilitates the breakdown of tablets once they reach the gastrointestinal tract.

MAGNESIUM STERATE:

Magnesium stearate is a commonly used lubricant in the manufacturing of herbal tablets. It is a fine, white powder composed of magnesium salt of stearic acid, a long-chain fatty acid. Though chemically simple, it plays a critical role in tablet production by reducing friction between the tablet material and the surfaces of processing equipment such as tablet punches and dies.

LACTOSE:

Lactose is a widely used diluent (filler) in herbal tablet formulations. It is a natural disaccharide sugar composed of glucose and galactose, typically derived from milk. In tablet manufacturing, lactose serves to increase the bulk of the formulation when the active herbal ingredients are present in small quantities, ensuring consistent tablet size, weight, and ease of processing.

MANUFACTURING OF TABLET:

In the tablet pressing process, the appropriate amount of active ingredient must be in each tablet. Hence, all the ingredients should be well-mixed. If a sufficiently homogenous mix of the components cannot be obtained with simple blending processes, the ingredients must be granulated prior to compression to assure an even distribution of the active compound in the final tablet. Two basic techniques are used to granulate powders for compression into a tablet: wet granulation and dry granulation.

Method of preparation:

Types of granulations:

  • Wet granulation
  • Dry granulation

o Wet Granulation

The most widely used process of agglomeration in pharmaceutical industry is wet granulation. Wet granulation process simply involves wet massing of the powder blend with a granulating liquid, wet sizing and drying.

? FORMULATION OF TABLET

Preparation of Granules:

Wet Granulation

Important steps involved in the wet granulation:

  1. drug and excipients accurately weighed and dry mixed manually in mortar. except  lubricant and glidant.
  2. Drug and excipients were passed through 100# sieve.
  3. Wet mass pass through sieve was prepared using mucilage of gum as a binder
  4. which was previously prepared in sufficient water using the concentration mentioned in table
  5. Mixing of binder solution with powder mixture to form wet mass screens.
  6. Wet mass was passed through 20# sieve and obtained granules.

Fig. granulations of wet mass of Tablet

  1. Drying of moist granules for 60min at temperature not exceeding 60oC
  2. The dried granules were passed through 20# sieve
  3. Mixing of screened granules with disintegrant, glidant, and lubricant.

  Final dry granules

Fig. final dry granules

These granules were evaluated for angle of repose, bulk density, tapped density.

Preparation herbal tablets:

Magnesium stearate and Agar-Agar powder were sieved through a 100# sieve and were first mixed for 30 min. This mixture was added in 20- 40 # Omega 3 fatty acids granules prepared as above, and the mixing was continued for further 5 min. Tablets of 300 mg in weight and 12 mm in diameter were prepared by compression using a single-punch tablet compression machine. Tablets are prepared by forcing particles into close proximity to each other by powder compression, which enables the particles to cohere into a porous, solid specimen of defined geometry. The compression takes place in a die by the action of two punches, the lower and the upper, by which the compressive force is applied. Powder compression is defined as the reduction in volume of a powder owing to the application of a force. Because of the increased proximity of particle surfaces accomplished during compression, bonds are formed between particles which provide coherence to the powder i.e. a compact is formed. Compaction is defined as the formation of a solid specimen of defined geometry by powder compression.

Process of tablet formation can be divided into two stages:

1. Die filling

This is normally accomplished by gravitational flow of the powder from a hopper via the die table into the die. The die is closed at its lower end by the lower punch.

2. Tablet formation

The upper punch descends and enters the die and the powder is compressed until a tablet is formed. During the compression phase, the lower punch can be stationary or can move upwards in the die. After maximum applied force is reached, the upper punch leaves the powder, i.e. the decompression phase. During this phase the lower punch rises until its tip reaches the level of the top of the die. The tablet is subsequently removed from the die table by a pushing device.

fig: final compressed tablet

FORMULATION TABLE OF HERBAL TABLET:

Sr no

Ingredient

F1

(MG)

F2

(MG)

F3

(MG)

USE

1

CURCUMIN

100

100

100

API

2

VITAMIN E

60

50

50

API

3

GARLIC

40

50

50

API

4

ACACIA

50

40

50

BINDER

5

STARCH POWDER

10

20

10

BULKING AGENT

6

AGAR-AGAR POWDER

20

15

5

DISINTGERENT

7

MAGNESIUM STERATE

10

10

15

LUBRICANT

8

LACTOSE

10

15

20

DILUENT

 

TOTAL

300 mg

300mg

300 mg

 

? EVALUTION OF TABLET:

Loss on drying:

The method adopted was that specified for acacia in the British Pharmacopoeia. One gram of the sample was transferred into each of several Petri dishes and then dried in an oven (NOVA Thermostatic Hot Air Oven) at 105°C until a constant weight was obtained. The moisture content was then determined as the ratio of weight of moisture loss to weight of sample, expressed as a percentage.

PH:

This was done by shaking a 1%w/v dispersion of the sample in water for 5min and the pH determined using a pH

Friability Test:

To evaluate the degree of friability of the tablets from each batch, ten tablets were randomly selected, dusted and weighed. The tablets were placed in a Roche fryolator (Eweka, Germany) and subjected to its tumbling actions at 25 rpm for 4min. afterwards; the tablets were once again dusted and reweighed to determine the percentage loss of weight.

Disintegration Test (D.T.):

Six tablets from each batch were utilized for disintegration studies in distilled water at 37°C using disintegration test apparatus (Electro lab, India). The disintegration time was taken to be the time no granule of any tablet was left on the mesh of the apparatus.

Hardness Test:

A Monsanto tablet hardness tester (Copley Scientific Ltd, U.K.) was employed to determine the mechanical strength of the tablets. Test was performed in triplicate.

RESULTS AND DISCUSSION:

The herbal tablet was successfully formulated using flaxseed and walnut powders as natural sources of Omega-3 fatty acids. The tablets were prepared using the Wet granulation study method, ensuring ease of manufacturing and cost-effectiveness.

1. Physical Evaluation:

The tablets showed good uniformity in weight, with variations within acceptable pharmacopeial limits. Hardness was found to be optimal, ensuring mechanical strength during handling and packaging. The disintegration time was within 15 minutes, which is suitable for immediate-release herbal formulations.

2. Chemical Evaluation:

The Omega-3 content, specifically alpha-linolenic acid (ALA), was successfully retained in the formulation. This was confirmed through GC or HPLC analysis. The tablet formulation was stable under accelerated storage conditions over a 3-month observation period.

Table No.2: Post -compression test/ Evaluation of Formulation

Sr.no

Physical Appearance

F1 to F3

1

Color

yellow

2

Odor

Pungent

3

Taste

Bitter

4

Shape

Round

5

Diameter (cm)

0.6

6

Width (cm)

0.3

Table No.3: Post Compression test / Evaluation of formulation

Sr.no

Evaluation of Parameter

F1

F2

F3

1

Weight Variation (gm)

0.28

0.26

0.24

2

Friability (%)

0.44

0.46

0.48

3

Hardness Test (kg/cm)

4.30

4.32

4.35

4

Thickness Test (mm)

3

3

3

5

Disintegration Time (min)

4

5

7

CONCLUSION

This herbal blood thinning tablet combines the natural benefits of curcumin, garlic, and vitamin E to help support healthy circulation and reduce the risk of abnormal blood clotting. Each of these ingredients plays a unique role: Curcumin, the active compound in turmeric, has anti-inflammatory and blood-thinning properties. It helps prevent platelets in the blood from clumping together, which may reduce the risk of clots. Garlic is well-known for its heart health benefits. It naturally helps lower blood pressure and cholesterol, and it also has antiplatelet effects that help keep the blood flowing smoothly. Vitamin E is a powerful antioxidant that protects blood vessels from damage. It also has mild anticoagulant effects, which means it can help reduce the stickiness of blood platelets. Together, these ingredients may provide a natural, gentle alternative to pharmaceutical blood thinners, especially for people who are looking for plant-based or preventive options. However, because these ingredients can interact with medications or affect bleeding, it’s very important to consult a healthcare professional before starting this supplemen particularly if you're on any medications for blood pressure, heart disease, or clotting disorders.

REFERENCES

  1. Dong-Chan Kim1,#, Sae-Kwang Ku2,# & Jong-Sup Bae3,* 1Laboratory of Microvascular Circulation Research, NEUORNEX Inc. Daegu 711-823, College of Pharmacy, Research Institute of Pharmaceutical Sciences,
  2. WULAN FADINIE1, AZNAN LELO2, DADIK WAHYU WIJAYA3, SARMA NURSANI LUMBANRAJA41Department of Anesthesiology and Intensive Therapy, Universitas Sumatera Utara, Medan, Indonesia, 2Department of Pharmacology, Universitas Sumatera Utara, Medan, Indonesia, 3,4Department of Gynecology and Obstetric, Universitas Sumatera Utara, Medan, Indonesia
  3. Shrainer E. V., Nikolaychuk K. M., Khavkin A. I., Veremenko A. S., Levchenko I. D., Platonova P. Ya., Novikova M. F., Tumas A. S., Vergunova E. E., Davie, E. W. (1995) Biochemical and molecular aspects of the coagulation cascade. Thromb. Haemost. 74, 1-6.
  4. Davie, E. W., Fujikawa, K. and Kisiel, W. (1991) The coagu-lation cascade: initiation, maintenance, and regulation. Biochemistry 30, 10363-10370.
  5. Hoffman, M. M. and Monroe, D. M. (2005) Rethinking the coagulation cascade. Curr. Hematol. Rep. 4, 391-396.
  6. Hoffmann, J. N., Vollmar, B., Romisch, J., Inthorn, D., Schildberg, F. W. and Menger, M. D. (2002) Antithrombin ef-fects on endotoxin-induced microcirculatory disorders are mediated mainly by its interaction with microvascular endothelium. Crit. Care. Med. 30, 218-225.
  7. Monroe, D. M., Hoffman, M. and Roberts, H. R. (2002) Platelets and thrombin generation. Arterioscler. Thromb. Vasc. Biol. 22, 1381-1389.
  8. Quinn, C., Hill, J. and Hassouna, H. (2000) A guide for diag-nosis of patients with arterial and venous thrombosis. Clin. Lab. Sci. 13, 229-238.
  9. Della Valle, P., Crippa, L., Garlando, A. M., Pattarini, E., Safa, Vigano D'Angelo, S. and D'Angelo, A. (1999) Interference of lupus anticoagulants in prothrombin time as-says: implications for selection of adequate methods to optimize the management of thrombosis in the anti phos-pholipid-antibody syndrome. Hematological 84, 1065- 1074.

Reference

  1. Dong-Chan Kim1,#, Sae-Kwang Ku2,# & Jong-Sup Bae3,* 1Laboratory of Microvascular Circulation Research, NEUORNEX Inc. Daegu 711-823, College of Pharmacy, Research Institute of Pharmaceutical Sciences,
  2. WULAN FADINIE1, AZNAN LELO2, DADIK WAHYU WIJAYA3, SARMA NURSANI LUMBANRAJA41Department of Anesthesiology and Intensive Therapy, Universitas Sumatera Utara, Medan, Indonesia, 2Department of Pharmacology, Universitas Sumatera Utara, Medan, Indonesia, 3,4Department of Gynecology and Obstetric, Universitas Sumatera Utara, Medan, Indonesia
  3. Shrainer E. V., Nikolaychuk K. M., Khavkin A. I., Veremenko A. S., Levchenko I. D., Platonova P. Ya., Novikova M. F., Tumas A. S., Vergunova E. E., Davie, E. W. (1995) Biochemical and molecular aspects of the coagulation cascade. Thromb. Haemost. 74, 1-6.
  4. Davie, E. W., Fujikawa, K. and Kisiel, W. (1991) The coagu-lation cascade: initiation, maintenance, and regulation. Biochemistry 30, 10363-10370.
  5. Hoffman, M. M. and Monroe, D. M. (2005) Rethinking the coagulation cascade. Curr. Hematol. Rep. 4, 391-396.
  6. Hoffmann, J. N., Vollmar, B., Romisch, J., Inthorn, D., Schildberg, F. W. and Menger, M. D. (2002) Antithrombin ef-fects on endotoxin-induced microcirculatory disorders are mediated mainly by its interaction with microvascular endothelium. Crit. Care. Med. 30, 218-225.
  7. Monroe, D. M., Hoffman, M. and Roberts, H. R. (2002) Platelets and thrombin generation. Arterioscler. Thromb. Vasc. Biol. 22, 1381-1389.
  8. Quinn, C., Hill, J. and Hassouna, H. (2000) A guide for diag-nosis of patients with arterial and venous thrombosis. Clin. Lab. Sci. 13, 229-238.
  9. Della Valle, P., Crippa, L., Garlando, A. M., Pattarini, E., Safa, Vigano D'Angelo, S. and D'Angelo, A. (1999) Interference of lupus anticoagulants in prothrombin time as-says: implications for selection of adequate methods to optimize the management of thrombosis in the anti phos-pholipid-antibody syndrome. Hematological 84, 1065- 1074.

Photo
Komal Chavan
Corresponding author

Gajanan Maharaj college of pharmacy, nipani, chhatrapati Sambhaji, maharashtra

Photo
Uday Jogpete
Co-author

Gajanan Maharaj college of pharmacy, nipani, chhatrapati Sambhaji, maharashtra

Komal Chavan, Uday Jogpete, Research Paper on Formulation and Evaluation of Herbal Blood Thining Tablet, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 6, 5010-5017. https://doi.org/10.5281/zenodo.15747168

More related articles
Nanotechnology In Parkinson's Disease...
Taufik Mulla, Mihir Parmar, Dev Gandhi, Deep Parekh, Hunedali Tin...
Comprehensive Review on Semen Production, Prematur...
Mohd Vaseem, Abdulla Ansari, Md Furquan Khan, Nayeem Ahmad, Mohd ...
Review On Nanoparticle : Nano Vehicles For Antican...
Namrata Pawar, Nikam Harshada D., ...
Related Articles
Understanding Neonatal Encephalopathy: Causes Symptoms, and Management ...
Dewanjali Rathore, Aryan Sahu, Shubham Deshmukh, Vivek sahu, Aditya kumar, Prince Suryavanshi, ...
A Review on Permeation Enhancer of Microemulsion Gels for Transdermal Drug Deliv...
Syed Saif Ullah , Dr. Deepesh Lall, Dr. Ritesh Jain, Anil Kumar Manhar, Vivek Kumar Sinha, ...
Artificial Intelligence: A Review on AI Powered Applications in Pharmacy ...
Dr. Shital Dange, Vaishnavi Latthe, Samruddhi Paramane, Sanika Patil, Arpita Mali, Triveni Rugge, ...
Nanotechnology In Parkinson's Disease...
Taufik Mulla, Mihir Parmar, Dev Gandhi, Deep Parekh, Hunedali Tinwala, ...
More related articles
Nanotechnology In Parkinson's Disease...
Taufik Mulla, Mihir Parmar, Dev Gandhi, Deep Parekh, Hunedali Tinwala, ...
Comprehensive Review on Semen Production, Premature Ejaculation, Contributing Fa...
Mohd Vaseem, Abdulla Ansari, Md Furquan Khan, Nayeem Ahmad, Mohd Saidurrehman, Syed Shariq, Mohd Abi...
Nanotechnology In Parkinson's Disease...
Taufik Mulla, Mihir Parmar, Dev Gandhi, Deep Parekh, Hunedali Tinwala, ...
Comprehensive Review on Semen Production, Premature Ejaculation, Contributing Fa...
Mohd Vaseem, Abdulla Ansari, Md Furquan Khan, Nayeem Ahmad, Mohd Saidurrehman, Syed Shariq, Mohd Abi...